Update on reporting of non-serious ADRs using the Industry VigiFlow module - SAHPRA

Update on reporting of non-serious ADRs using the Industry VigiFlow module

Update on reporting of non-serious ADRs using the Industry VigiFlow module

This document provides all holders of certificates of registration (HCRs) or applicants with an update on the retrospective submission of non-serious post-marketing adverse drug reaction reports for human medicines through the Industry eReporting VigiFlow module.

Download latest version
Document Number: PV04-2026/27
Version: 1
Date Updated: 18/11/2026
File Type: www
Category: Communication to industry
Unit: Clinical Evaluations Management, Pharmacovigilance